Table 1.
Classification of the items of the pre-test and post-test
| Codes | Items | Reponses |
|---|---|---|
| Essential knowledge to diagnose and treat a simple HTA: no sign of complications (simple HTA) | ||
| CIS-1 Diagnosis | HTA if BP is 140–159 and/or 90–99 or higher than those numbers in the office | yes |
| CIS-1 Medical treatment | Could we stop treatment if BP became normal? | no |
| CIS-2 Medical treatment | Which antihypertensor should be prescribed first intention at for a patient at risk of stroke or IC to the CSB? | diuretics (thiazide) |
| CIS-3 Medical treatment | Among the following medicines, indicate the financially accessible ones for the hypertensive Malagasy: diuretic thiazides, beta blockers, calcium antagonists, inhibitors of converting enzymes (short-acting/captopril), antagonists of angiotensin 2 (ARA2) receptors | diuretics and inhibitors of converting enzymes (short-acting/captopril) |
| CIS-1 Hygiene-dietetics measurement | A reduction in overweight involves a reduction in the numbers of BP | yes |
| CIS-1 Follow-up | Among the following proposals on the follow-up of the HTA, select the ones that are correct: weekly during the first six months of treatment, monthly during the first six months of treatment, semi-monthly after 6 months of treatment, quarterly after 6 months of treatment. | Monthly during the first six months of the treatment and quarterly after six months of the treatment. |
| CIS-2 Follow-up | Should we stop the treatment of the HTA in the event of the appearance of side effects? | no |
| Essential knowledge for resistant hypertension—i.e., not stabilized by the drugs available in the HBC—and complicated, i.e., presenting signs of repercussions to other organs (resistant and complicated HTA) | ||
| CIRC-1 Medical treatment | The antihypertensor is prescribed first intention at for a patient at risk of renal insufficiency with the HBC | Diuretics: furosemide, inhibitors of the converting enzymes at short-acting time(captopril) |
| CIRC-2 Medical treatment | Among following associations of the antihypertensor—IEC + sartan, IEC + diuretics, IEC + beat-blocking, IEC + inhibiting calcic—which are synergistic? | IEC + diuretics;IEC + inhibiting calcic |
| CIRC-3 Medical treatment | In a hypertensive crisis, in which case we do not recommend antihypertensive treatment in an emergency? | Vascular accident of the ischemic type |
| CIRC-4 Medical treatment | Among following associations of the antihypertensors Beta Blocker + Vérapamil, Beta Blocker + Dihydropyridin, Blocking alpha + Dihydropyridin, Converting enzyme Inhibitor + diuretics to save potassium, Converting enzyme Inhibitor + Vérapamil, which are disadvised? | Beta Blocker + Vérapamil; Converting enzyme Inhibitor + diuretics to save potassium |
| CIRC-1 hygiene-dietetics measurement | Which are the hygiene-dietetics measurements adapted to the Malagasy context: a pinch of salt with each mealto avoid food or industrial preparations rich with salt (canned, pork-butchery, sauces), stopping alcohol consumption, stopping tobacco consumption, preparing a family dish to avoid fatty meats, or drinking at least 1.5 l of water per day? | All |
| CIRC-1 Follow-up | What are the side effects that could appear when prescribing an inhibitor of converting enzymes? | a rise in the creatininemy, a cough |
| Useful Knowledge for HTA (useful HTA) | ||
| CU-1 Diagnosis | True statement regarding the HTA: A. has a blood pressure > 140/90 mmHg is used as definition of the HTA because it is starting from this level that the risk of complication appears; B .the isolated systolic HTA is defined by a systolic pressure > 140 mmHg and a diastolic pressure < 90 mmHg; C. the curable forms of HTA account for approximately 5% of all cases of HTA; D. the most frequent complications of hypertension are those related to atherosclerosis. | b and d |
| CU-2 Diagnosis | The indicators of risk of HTA are age, overweight, diabetes, stress, alcohol, excessive consumption of sodium | yes |
| CU-3 Diagnosis | Exact proposal of the HTA: the values of reference are different at the health center or the hospital and residence | no |
| CU-1 Medical treatment | Which is the false statement about the HTA: A. It has a level of total cardiovascular risk incurred by hypertension that must logically lead to the decision of antihypertensor treatment; B. In the choice of a antihypertensor, the hypotensive effectiveness is additional to other properties, specific to each product; C. a hypertensive urgency is distinguished from a simple tensional push by the existence of signs of visceral suffering; D. hypertension is considered resistant when it cannot be controlled despite the association of 3 different active ingredients, including diuretics. | b |
| CU-2 Medical treatment | The goals of the treatment of the HTA is to normalize blood pressure numbers and to prevent the appearance of complications | yes |
| CU-1 Follow-up | The treatment by thiazidic diuretic justifies first-intention controls of the following parameters: kaliemy, creatininemy, clearance of creatinin, uricemy | yes |
| CU-1 Complication | Which can be the complications of the HTA? | Stroke, left ventricular hypertrophy, Arteriopathy of the lower extremities |